Literature DB >> 15006015

The need for trial identifiers.

Elizabeth Wager1.   

Abstract

The medical literature is distorted by publication bias, duplicate publication and under-reporting of clinical trials. This can create problems in systematic numbering systems. The inclusion of trial identifiers reviews and meta-analysis which are increasingly used as the basis for evidence-based guidelines and therefore for treatment decisions. Various schemes for identifying trials and their associated publications are reviewed. These include trial registers and trial in all publications could greatly enhance the value of the medical literature and increase the robustness of systematic reviews and meta-analyses.

Keywords:  Biomedical and Behavioral Research

Mesh:

Year:  2004        PMID: 15006015     DOI: 10.1185/030079903125002883

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  5 in total

1.  The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).

Authors:  O Bruyere; J A Kanis; M-E Ibar-Abadie; N Alsayed; M L Brandi; N Burlet; D L Cahall; A Chines; J-P Devogelaer; W Dere; N Goel; N Hughes; J-M Kaufman; S Korte; B H Mitlak; D Niese; R Rizzoli; L C Rovati; J-Y Reginster
Journal:  Osteoporos Int       Date:  2010-03-18       Impact factor: 4.507

2.  "Good Publication Practice for Pharmaceutical Companies": where are we now?

Authors:  Elizabeth Wager
Journal:  MedGenMed       Date:  2005-04-18

3.  Trial registration numbers are underreported in biomedical publications.

Authors:  Fleur T van de Wetering; Rob J P M Scholten; Tamara Haring; Michael Clarke; Lotty Hooft
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

Review 4.  Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.

Authors:  Andrea Cipriani; Toshi A Furukawa; Georgia Salanti; Anna Chaimani; Lauren Z Atkinson; Yusuke Ogawa; Stefan Leucht; Henricus G Ruhe; Erick H Turner; Julian P T Higgins; Matthias Egger; Nozomi Takeshima; Yu Hayasaka; Hissei Imai; Kiyomi Shinohara; Aran Tajika; John P A Ioannidis; John R Geddes
Journal:  Lancet       Date:  2018-02-21       Impact factor: 79.321

5.  Prospective registration and reporting of trial number in randomised clinical trials: global cross sectional study of the adoption of ICMJE and Declaration of Helsinki recommendations.

Authors:  Mustafa Al-Durra; Robert P Nolan; Emily Seto; Joseph A Cafazzo
Journal:  BMJ       Date:  2020-04-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.